Why the study?
Does proximal pulmonary vascular stiffness assessed by CMR correlate with RV performance and predict clinical outcomes in children with PAH?
Does proximal pulmonary vascular stiffness assessed by CMR correlate with RV performance and predict clinical outcomes in children with PAH?
Non-invasive CMR assessment of MPA stiffness and PWV may serve as useful prognostic markers of disease activity and RV dysfunction in children with PAH.
Answers are grounded in this paper and cite their sources.
May support CMR-derived MPA stiffness and PWV as prognostic markers in pediatric PAH; extends adult data but leaves open prospective validation.
MPA stiffness assessed by non-invasive CMR was increased in children with PAH and correlated with RV performance, suggesting that MPA stiffness is a major contribution to RV dysfunction. PWV is predictive of moderate clinical outcomes, and may be a useful prognostic marker of disease activity in children with PAH.
No takes yet. Share an insight, caveat, or question.
Friesen et al. (2018) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: